के बारे में ग्रेन्यूल्स इंडिया

• उद्योग Biotechnology & Drugs
• आईएसआईएन INE101D01020
• बीएसई कोड 532482
• एनएसई कोड GRANULES

Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceutical products segment. Its geographical segments include within India and outside India. The Company has a presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It produces and supplies Paracetamol, Metformin, Guaifenesin, and Methocarbamol APIs. It has over 10 manufacturing facilities, approximately eight of which are located in India and two in the United States. The Company sells its products in global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific, and India. Its subsidiaries include Granules USA Inc and Granules Europe Limited. It also owns Senn Chemicals AG, a contract development and manufacturing organization (CDMO) specializing in peptide development and manufacturing.

ग्रेन्यूल्स इंडिया मैनेजमेंट

• Krishna Chigurupati Executive Chairman of the Board, Managing Director
• Kandiraju Rao Chief Executive Officer, Joint Managing Director, Executive Director
• Mukesh Surana Chief Financial Officer
• P. N. Baskaran President - Head API Manufacturing and Operations
• Sanjay Kumar President and Chief Strategy and Sustainability Officer
• Ramraj Rangarajulu President and Head - Formulations Operations
• Atul Dhavle Chief Human Resources Officer
• Rajesh Kapoor Senior Vice President, Global Head of Quality
• G. N. Prashanth Senior Vice President & Head Corporate Quality
• Manikandan Ramalingam Senior Vice President & Head Formulation R&D